Inclisiran (sodium)

Produktübersicht

• Artikelname: Inclisiran (sodium)
• Artikelnummer: MCE-HY-132591A
• Hersteller Artikelnummer: HY-132591A
• Alternativnummer: MCE-HY-132591A-1MG,MCE-HY-132591A-5MG,MCE-HY-132591A-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: ALN-PCSsc (sodium)

Produktbeschreibung

Inclisiran sodium is a double-stranded small interfering RNA (siRNA) molecule. Inclisiran sodium inhibits the transcription of PCSK9. Inclisiran sodium inhibits Pyroptosis, activates PPARgamma, and reduces NLRP3, cleaved caspase-1, IL-1beta, and IL-18. Inclisiran sodium has anti-inflammatory, lipid-regulating and anti-atherosclerotic activities. Inclisiran sodium can be used in researches of hyperlipidemia and cardiovascular disease (CVD)[1][2][3].

Produkteigenschaften

• Molekulargewicht: 16339.6 (free acid)
• Reinheit: 98.91
• Formel: C529H707F12N176O316P43S6.xNa
• Target-Kategorie: Caspase,Interleukin Related,NOD-like Receptor (NLR),PCSK9,PPAR,Pyroptosis,Small Interfering RNA (siRNA)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Oligonucleotides